Literature DB >> 20460511

Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells.

Patrizia Cammareri1, Alessandro Scopelliti, Matilde Todaro, Vincenzo Eterno, Federica Francescangeli, Mary Pat Moyer, Antonino Agrusa, Francesco Dieli, Ann Zeuner, Giorgio Stassi.   

Abstract

Colorectal cancer stem cells (CR-CSC) are responsible for the generation and maintenance of intestinal tumors and are highly resistant to conventional chemotherapeutic agents. Aurora-A, a serine-threonine kinase involved in mitosis regulation, plays multiple key functions in tumor initiation and progression. We found that Aurora-A is overexpressed in primary colorectal tumor cells, in the CR-CSC fraction, and in stem cell-derived differentiated cells, compared with normal colon tissue. Aurora-A expression was functionally linked to centrosome amplification in CR-CSC, as indicated by the decrease in cells with multiple centrosomes that followed Aurora-A silencing. Knockdown of Aurora-A resulted in growth inhibition of CR-CSC, alteration of cell cycle kinetics, and downregulation of the expression levels of antiapoptotic Bcl-2 family members, strongly sensitizing to chemotherapy-induced cell death. Moreover, Aurora-A silencing compromised the ability to form tumor xenografts in immunocompromised mice and reduced the migratory capacity of CR-CSC. Altogether, these results indicate that Aurora-A is essential for CR-CSC regeneration and resistance to cytotoxic stimuli and suggest that therapies directed against Aurora-A may effectively target the stem cell population in colorectal cancer. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460511     DOI: 10.1158/0008-5472.CAN-09-3953

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  63 in total

1.  AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

Authors:  Ahmed Katsha; Janet Arras; Mohammed Soutto; Abbes Belkhiri; Wael El-Rifai
Journal:  Mol Oncol       Date:  2014-06-03       Impact factor: 6.603

2.  ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients.

Authors:  Brian J Wilson; Tobias Schatton; Qian Zhan; Martin Gasser; Jie Ma; Karim R Saab; Robin Schanche; Ana-Maria Waaga-Gasser; Jason S Gold; Qin Huang; George F Murphy; Markus H Frank; Natasha Y Frank
Journal:  Cancer Res       Date:  2011-06-07       Impact factor: 12.701

3.  Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells.

Authors:  Ahmed Katsha; Lihong Wang; Janet Arras; Omar M Omar; Jeffrey Ecsedy; Abbes Belkhiri; Wael El-Rifai
Journal:  Clin Cancer Res       Date:  2017-01-10       Impact factor: 12.531

4.  Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.

Authors:  Laura W Goff; Nilofer S Azad; Stacey Stein; Jennifer G Whisenant; Tatsuki Koyama; Ulka Vaishampayan; Howard Hochster; Roisin Connolly; Amy Weise; Patricia M LoRusso; Safia N Salaria; Wael El-Rifai; Jordan D Berlin
Journal:  Invest New Drugs       Date:  2018-09-06       Impact factor: 3.850

Review 5.  Insights into the non-mitotic functions of Aurora kinase A: more than just cell division.

Authors:  Giulia Bertolin; Marc Tramier
Journal:  Cell Mol Life Sci       Date:  2019-09-27       Impact factor: 9.261

6.  Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.

Authors:  Jing Wang; Dmitri Mouradov; Xiaojing Wang; Robert N Jorissen; Matthew C Chambers; Lisa J Zimmerman; Suhas Vasaikar; Christopher G Love; Shan Li; Kym Lowes; Karl-Johan Leuchowius; Helene Jousset; Janet Weinstock; Christopher Yau; John Mariadason; Zhiao Shi; Yuguang Ban; Xi Chen; Robert J C Coffey; Robbert J C Slebos; Antony W Burgess; Daniel C Liebler; Bing Zhang; Oliver M Sieber
Journal:  Gastroenterology       Date:  2017-06-16       Impact factor: 22.682

Review 7.  Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies.

Authors:  Shinji Tanaka; Shigeki Arii
Journal:  J Gastroenterol       Date:  2011-02-25       Impact factor: 7.527

Review 8.  The Unexpected Roles of Aurora A Kinase in Gliobastoma Recurrences.

Authors:  Estelle Willems; Arnaud Lombard; Matthias Dedobbeleer; Nicolas Goffart; Bernard Rogister
Journal:  Target Oncol       Date:  2017-02       Impact factor: 4.493

9.  Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.

Authors:  Maria Laura De Angelis; Ann Zeuner; Eleonora Policicchio; Giorgio Russo; Alessandro Bruselles; Michele Signore; Sara Vitale; Gabriele De Luca; Emanuela Pilozzi; Alessandra Boe; Giorgio Stassi; Lucia Ricci-Vitiani; Carla Azzurra Amoreo; Alfredo Pagliuca; Federica Francescangeli; Marco Tartaglia; Ruggero De Maria; Marta Baiocchi
Journal:  Stem Cells Transl Med       Date:  2016-03-08       Impact factor: 6.940

10.  Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.

Authors:  Warapen Treekitkarnmongkol; Hiroshi Katayama; Kazuharu Kai; Kaori Sasai; Jennifer Carter Jones; Jing Wang; Li Shen; Aysegul A Sahin; Mihai Gagea; Naoto T Ueno; Chad J Creighton; Subrata Sen
Journal:  Carcinogenesis       Date:  2016-09-13       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.